SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Theragenics (TGX) on the up and up

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: ron keller who wrote (838)5/4/1998 9:17:00 PM
From: Ron Kline  Read Replies (1) of 1055
 
If that's the case than today was a great buying opportunity. The Entremed breakthrough may be a breakthrough but it's a long way to be selling any product to compete with THRX. When you are still dealing with mice you are a long way away to market. Think how long it took THRX to go to market with their product, and how long it took before it really started paying off. By the time Entremed ever goes to market THRX will be a whole different company by that time. I bought 1/4 more shares today on the weakness.
Ron
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext